<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003745'>Sporadic</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (sCRC) is one of the most frequent types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in Europe </plain></SENT>
<SENT sid="1" pm="."><plain>Despite understanding of its <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, the metastatic process is not yet clear </plain></SENT>
<SENT sid="2" pm="."><plain>In this article, we review the most significant genetic and proteomic advances that have been made in regards to research of the sCRC metastatic process, and the new biomarkers that are able to predict disease prognosis or response to treatments, in order to define personalized medicine </plain></SENT>
</text></document>